K-Group Beta_ZN-c3-005 GOG-3066: A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN-c3 in Subjects with High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (Part 1b closed to enrollment 13-Jun-2024)

Objective

Clinical Trial Details

Principal Investigator(s)

David Starks, MD

Clinical Trial Categories

• Cancer
• Gynecologic Cancer

Contact

Gynecology Breast Coordinators at 605-322-7536
or gyn.breastresearch@avera.org